Healthcare
Wednesday, January 18, 2017
BRIEF-Richard Uihlein reports 7.89 pct stake in Galectin Therapeutics
* Richard Uihlein reports 7.89 percent stake in Galectin
Therapeutics Inc as of Dec 22 - SEC filing
Source text: (http://bit.ly/2jMCBRA)
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment